Weight-loss drugs in India may become up to 60% cheaper as semaglutide patents expire on March 20, allowing generic launches by major pharma companies. While prices could drop to Rs3,500-Rs4,000 monthly, doctors warn against unsupervised use, stressing medical evaluation, lifestyle changes, and long-term monitoring to prevent serious side effects and misuse. , Health, Times Now |
